Thrombosis and Anticoagulation Program | Overview

LIke ThisLIke ThisLIke ThisLIke ThisLIke This

Contact the Thrombosis and Anticoagulation Program

Led by Alan Michelson, MD, one of the world’s leading authorities on platelets and platelet disorders, the Dana-Farber/Boston Children’s Cancer and Blood Disorders Center’s Thrombosis and Anticoagulation Program treats children with all forms of blood clots and clotting disorders. The disorders we treat in the program include pulmonary embolism, sinus venous thrombosis, deep vein thrombosis, and arterial thrombosis. Our emphasis is on preventing blood clots, especially thrombosis, before they occur and treating them if they do.

Dana-Farber/Boston Children’s is an integrated pediatric hematology and oncology partnership between Dana-Farber Cancer Institute and Boston Children’s Hospital. We offer, in one specialized program, the full spectrum of services that are needed for diagnosis, treatment and ongoing care of even the rarest and hard-to-treat conditions.

Patients seen through the Thrombosis and Anticoagulation Program are treated by a multidisciplinary team of specialists with deep expertise in the conditions we treat. Our team also includes pediatric subspecialists with extensive experience treating blood clots and a designated nurse who specializes in medications that thin the blood and prevent clots from forming.

Learn more about our Thrombosis and Anticoagulation Program on the Dana-Farber/Boston Children’s website.

We are grateful to have been ranked #1 on U.S. News & World Report's list of the best children's hospitals in the nation for the third year in a row, an honor we could not have achieved without the patients and families who inspire us to do our very best for them. Thanks to you, Boston Children's is a place where we can write the greatest children's stories ever told.”
- Sandra L. Fenwick, President and CEO

Boston Children's Hospital 300 Longwood Avenue, Boston, MA 02115 617-355-6000 | 800-355-7944

Close